On ECHEMI
Home > Drugs > Suzhou Dawnrays Pharmaceutical Co., Ltd.
Suzhou Dawnrays Pharmaceutical Co., Ltd.
  • Founded in:

    1995-12-08
  • Country:

    China China
  • Address:

    No. 268, Minfeng Road, Wuzhong Economic Development Zone, Suzhou
  • Tax NO.:

    913205006283933800
  • Registered Funds:

    $131.5 million
  • Website:

  • Email:

Related Drugs
Metformin Hydrochloride Tablets
250mg metformin hydrochloride 1.25mg glibenclamide.
Name Description Content CAS NO. Registered Holders
1,1-DIMETHYLBIGUANIDE HYDROCHLORIDE

Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization; increase the utilization of glucose by non-insulin-dependent tissues; inhibit hepatic gluconeogenesis and reduce hepatic glucose output; inhibit the uptake of glucose by intestinal wall cells; inhibit the biosynthesis and storage of cholesterol and reduce blood triglyceride and total cholesterol levels.

More

Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization; increase the utilization of glucose by non-insulin-dependent tissues; inhibit hepatic gluconeogenesis and reduce hepatic glucose output; inhibit the uptake of glucose by intestinal wall cells; inhibit the biosynthesis and storage of cholesterol and reduce blood triglyceride and total cholesterol levels.

250mg 15537-72-1 55
Glibenclamide

It can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes. Unlike insulin, it does not promote fat synthesis and has no obvious blood sugar lowering effect on normal people. It generally does not cause hypoglycemia when used alone in patients with type 2 diabetes.

More

It can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes. Unlike insulin, it does not promote fat synthesis and has no obvious blood sugar lowering effect on normal people. It generally does not cause hypoglycemia when used alone in patients with type 2 diabetes.

1.25mg 10238-21-8 28
Amlodipine Besylate Tablets
3-Ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate benzenesulfonate
Name Description Content CAS NO. Registered Holders
Amlodipine Besylate

Amlodipine is a calcium blocker (also known as a slow channel blocker or calcium ion antagonist) that blocks calcium ions from crossing the membrane into myocardial and vascular smooth muscle cells.

More

Amlodipine is a calcium blocker (also known as a slow channel blocker or calcium ion antagonist) that blocks calcium ions from crossing the membrane into myocardial and vascular smooth muscle cells.

111470-99-6 81
Amlodipine

Calcium blockers (also known as slow channel blockers or calcium antagonists) block the entry of calcium ions across the membrane into myocardial and vascular smooth muscle cells.

More

Calcium blockers (also known as slow channel blockers or calcium antagonists) block the entry of calcium ions across the membrane into myocardial and vascular smooth muscle cells.

88150-42-9 2
Amlodipine Besylate
Name Description Content CAS NO. Registered Holders
Amlodipine Besylate

Extract from the above information

More

Extract from the above information

111470-99-6 81
Levocetirizine hydrochloride
Levocetirizine hydrochloride. Chemical name: R-(-)2-[2-[4-[4-(chlorophenyl)benzyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride.
Name Description Content CAS NO. Registered Holders
Levocetirizine dihydrochloride

This product is an oral selective histamine H1 receptor antagonist. It has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and has a small central nervous system inhibitory effect.

More

This product is an oral selective histamine H1 receptor antagonist. It has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and has a small central nervous system inhibitory effect.

130018-87-0 22
Levocetirizine Hydrochloride Tablets
The main ingredient of this product is levocetirizine hydrochloride, and its chemical name is (R)-(-)-2-[2-(4-(4-chlorophenyl)benzyl)-1-piperazinyl)ethoxy]acetic acid dihydrochloride.
Name Description Content CAS NO. Registered Holders
Levocetirizine dihydrochloride

This product is an oral selective histamine H1 receptor antagonist. It has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and has a small central nervous system inhibitory effect.

More

This product is an oral selective histamine H1 receptor antagonist. It has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and has a small central nervous system inhibitory effect.

130018-87-0 22
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.